Russian President Vladimir Putin on Wednesday introduced the second doubtful approval of a COVID-19 vaccine that has not been evaluated in scientific trials.
The vaccine, dubbed EpiVacCorona, is alleged to be an artificial peptide-based vaccine, which makes use of fragments of the pandemic virus, SARS-CoV-2, to spur protecting immune responses in these vaccinated. It was developed by Vector State Virology and Biotechnology Middle, a former Soviet bioweapons analysis lab.
Like the primary Russian-approved vaccine, whether or not EpiVacCorona is definitely protected and efficient is totally unknown. In a televised information convention, Putin mentioned that early trials involving 100 individuals have been profitable. However researchers haven’t revealed any security or efficacy knowledge from these trials. Russian well being officers have mentioned they’re nonetheless reviewing the vaccine for “security and high quality” however declined to offer any extra data on the vaccine, knowledge, or approval course of.
Learn 5 remaining paragraphs | Feedback